Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumoursDavid Sefrioui, Frédéric FIORE, France Blanchard et al.|British Journal of Cancer|2017Cited by 122
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trialPhilippe Merle, Gabriele Luppi, François Habersetzer et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 61
Impact of nutritional parameter variations during definitive chemoradiotherapy in locally advanced oesophageal cancerAude Di Fiore, Frédéric Di Fiore, Stéphane Lecleire et al.|Digestive and Liver Disease|2014Cited by 32
Fully versus partially covered self-expandable metal stents in benign esophageal stricturesAlice Gangloff, Pierre Michel, Stéphane Lecleire et al.|Diseases of the Esophagus|2014Cited by 30